Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PharmaEssentia | Taiwan | Healthcare | Biotechnology & Medical Research | NT$192.41B | 64.5x | 0.12 | NT$578 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 35.6% Upside | Upgrade to Pro+ | |
Lumosa Therapeutics | TPEX | Healthcare | Biotechnology & Medical Research | NT$38.42B | -95.2x | 0.28 | NT$227.50 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 1.1% Upside | Upgrade to Pro+ | |
Polaris Group | Taiwan | Healthcare | Biotechnology & Medical Research | NT$34.92B | -15.5x | 0.2 | NT$46.80 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
TaiMed Biologics | TPEX | Healthcare | Biotechnology & Medical Research | NT$26.35B | -179.4x | -9.25 | NT$96.50 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 14% Upside | Upgrade to Pro+ | |
Tanvex BioPharma | Taiwan | Healthcare | Biotechnology & Medical Research | NT$17.86B | -6.8x | -0.32 | NT$75 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sunmax BioTech | TPEX | Healthcare | Biotechnology & Medical Research | NT$16.48B | 23.6x | 1.16 | NT$302.50 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
PharmaEngine | TPEX | Healthcare | Biotechnology & Medical Research | NT$15.45B | 8.8x | 0.02 | NT$107.50 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 11.6% Upside | Upgrade to Pro+ | |
OBI Pharma | TPEX | Healthcare | Biotechnology & Medical Research | NT$15.17B | -6.1x | 0.05 | NT$57.70 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Foresee Pharmas | TPEX | Healthcare | Biotechnology & Medical Research | NT$13.09B | -12.4x | -1.93 | NT$84.60 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 49.5% Upside | Upgrade to Pro+ | |
Gongwin Biopharm | TPEX | Healthcare | Biotechnology & Medical Research | NT$12.98B | -117.1x | -3.14 | NT$102.50 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Mycenax Biotech | TPEX | Healthcare | Biotechnology & Medical Research | NT$8.84B | -16.4x | -0.65 | NT$42.80 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medigen BioTech | TPEX | Healthcare | Biotechnology & Medical Research | NT$4.88B | -11.8x | -0.38 | NT$35 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bionet | TPEX | Healthcare | Biotechnology & Medical Research | NT$4.08B | 72.4x | -2.23 | NT$80.40 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Senhwa Biosciences | TPEX | Healthcare | Biotechnology & Medical Research | NT$3.95B | -13.3x | -5.19 | NT$44.25 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SINEW Pharma | TPEX | Healthcare | Biotechnology & Medical Research | NT$3.64B | -20.3x | 0.95 | NT$51 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
TaiRx | TPEX | Healthcare | Biotechnology & Medical Research | NT$3.10B | -15.6x | -0.72 | NT$28.05 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
GlycoNex | TPEX | Healthcare | Biotechnology & Medical Research | NT$2.61B | -11.3x | 0.47 | NT$24.10 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Golden BioTech | TPEX | Healthcare | Biotechnology & Medical Research | NT$2.52B | -5.8x | 0.08 | NT$15.55 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Applied BioCode | Taiwan | Healthcare | Biotechnology & Medical Research | NT$2.32B | -9.7x | NT$22.55 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -2.4% Downside | Upgrade to Pro+ | ||
Genesis Genetics Asia | TPEX | Healthcare | Biotechnology & Medical Research | NT$1.88B | 32.2x | 0.29 | NT$70.40 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Abnova | Taiwan | Healthcare | Biotechnology & Medical Research | NT$1.79B | 30.4x | 0.93 | NT$29.60 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Taiwan Advance Bio-Pharma | TPEX | Healthcare | Biotechnology & Medical Research | NT$1.44B | 67.4x | 0.44 | NT$16.05 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Genomics BioSci &Tech | TPEX | Healthcare | Biotechnology & Medical Research | NT$1.34B | -8.4x | 0.09 | NT$18.45 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Dv Biomed | TPEX | Healthcare | Biotechnology & Medical Research | NT$1.31B | 20.8x | -0.33 | NT$63.40 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Kim Forest Enterprise | Taiwan | Healthcare | Biotechnology & Medical Research | NT$1.24B | -7.7x | 0.17 | NT$23.05 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SynCore BioTech | TPEX | Healthcare | Biotechnology & Medical Research | NT$1.21B | 3,430x | 33.07 | NT$34.30 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Twi BioTech | TPEX | Healthcare | Biotechnology & Medical Research | NT$1.03B | -4.3x | 0.03 | NT$11.70 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Inalways | TPEX | Healthcare | Biotechnology & Medical Research | NT$929.95M | -1,110x | -11.28 | NT$18.80 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sofiva Genomics | TPEX | Healthcare | Biotechnology & Medical Research | NT$889.65M | 41.9x | -1.08 | NT$41.20 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BioLASCO Taiwan | TPEX | Healthcare | Biotechnology & Medical Research | NT$855.44M | 20.1x | -4.03 | NT$33.40 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
TaiwanJ Pharmas | TPEX | Healthcare | Biotechnology & Medical Research | NT$768.37M | -26x | -0.46 | NT$9.59 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Welgene Biotech | TPEX | Healthcare | Biotechnology & Medical Research | NT$551.15M | -422.3x | -8.93 | NT$23.65 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |